Skip to main content
. Author manuscript; available in PMC: 2016 May 27.
Published in final edited form as: JAMA. 2015 Feb 17;313(7):687–694. doi: 10.1001/jama.2015.280

Table 1. Participant Characteristics.

Varenicline (N = 760) Placebo (N = 750)
Demographic Characteristics
 Sex, n (%)
        Male 425 (55.9) 426 (56.8)
        Female 335 (44.1) 324 (43.2)
 Age, years
        Mean (SD) 44.7 (11.8) 44.4 (12.0)
        Range 19-79 18-78
 Race, n (%)
        White 476 (62.6) 463 (61.7)
        Black 36 (4.7) 47 (6.3)
        Asian 175 (23.0) 177 (23.6)
        Other 73 (9.6) 63 (8.4)

Smoking Characteristics
    Fagerström Test for Cigarette Dependencea, mean (SD) 5.5 (2.1) 5.6 (2.0)
    Age started smoking, years, mean (SD) 17.3 (4.3) 17.3 (4.4)
    Number of cigarettes per day in past month, mean (SD) 20.6 (8.5) 20.8 (8.2)
    Longest period of abstinence, days
              Since started smokingMedian (25th, 75th percentile) 30 (3, 240)272 21 (2, 180)206
              Mean
     In past year 0 (0, 0) 0 (0, 1)
              Median (25th, 75th percentile) 4 3
              Mean
 Number of serious quit attempts by any method, n (%)
      Since started smoking
               None             130 (17.1)             159 (21.2)
               One             191 (25.1)             188 (25.1)
               Two             139 (18.3)             110 (14.7)
               Three or more             300 (39.5)             293 (39.1)
a

Fagerström Test for Cigarette Dependence measures degree of cigarette dependence with scores ranging from 0 to 10 with higher scores indicating a higher degree of dependence.17

Abbreviations: N = all randomized participants; n = number of participants with the given characteristic; SD = standard deviation.